期刊
BRAIN BEHAVIOR AND IMMUNITY
卷 46, 期 -, 页码 50-54出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2015.01.014
关键词
ATL313; CGS21680; Myelin oligodendrocyte glycoprotein; Multiple sclerosis
资金
- Dogwood Pharmaceuticals, LLC
- NIH [DA02422, RC1-NS067807]
- Department of Defense [DM102108]
A single intrathecal dose of adenosine 2A receptor (A(2A)R) agonist was previously reported to produce a multi-week reversal of allodynia in two different models of neuropathic pain in addition to downregulating glial activation markers in the spinal cord. We aimed to determine whether a single intrathecal administration of an A(2A)R agonist was able to attenuate motor symptoms induced by experimental autoimmune encephalopathy. Two A(2A)R agonists (CGS21680 and ATL313) significantly attenuated progression of motor symptoms following a single intrathecal administration at the onset of motor symptoms. OX-42, a marker of microglial activation, was significantly attenuated in the lumbar spinal cord following A(2A)R administration compared to vehicle. Therefore, A(2A)R agonists attenuate motor symptoms of EAE by acting on A(2A)R in the spinal cord. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据